Updated January 29 at 9:29pm

EpiVax team publishes research on H7N9 flu; plans vaccines

PROVIDENCE – A research paper on the emerging threat from the H7N9 flu, written by Dr. Annie De Groot and her team at EpiVax, has been published by the journal Human Vaccines & Immunotherapeutics. More

To continue reading this article, please do one of the following.



health care

EpiVax team publishes research on H7N9 flu; plans vaccines

Posted:

PROVIDENCE – A research paper on the emerging threat from the H7N9 flu, written by Dr. Annie De Groot and her team at EpiVax, has been published by the journal Human Vaccines & Immunotherapeutics.

The article, “Low immunogenicity predicted for emerging avian-origin H7N9: Implication for influenza vaccine design,” detailed how De Groot and her team used well-established immunoinformatics tools to analyze the H7N9 protein sequences.

The research found that protein derived from closely related human-derived H7N9 strains contain fewer T cell epitopes than other recently circulating strains of influenza.

Based on that research, De Groot and her team have developed four separate vaccine recipes that are now in production.

EpiVax, a Providence-based bioscience firm, celebrated its 15th birthday on May 17 at its headquarters in the city’s Knowledge District. •

28~07, 052013 HEALTH CARE NEWS BRIEFS, EpiVax, 28~07, issue052013export.pbn

Comments

No comments on this story | Please log in to comment by clicking here
Please log in or register to add your comment
Latest News